$XBI $132.32 +2.7%
Want to access our searchable database of over 900 catalyst events and more? Try BiopharmIQ for 30 days free, no credit card required. Check it out here!
Covid Updates
$MRNA +6.9% Announces clinical progress from leading mRNA vaccine. source
Pipeline Updates
$LUMO +5.8% Hosting key opinion leader webinar on LUM-201 on April 27, 2021. source
$PRAX -16.7% Receives Orphan Drug Designation for PRAX-562. source
$IMAB +11% Uliledlimab selected for poster presentation at ASCO 2021. source
$AGEN -0.7% First patient dosed in agenT-797 iNKT cell therapy trial. source
$ARDX +8.9% Collaboration partner Kyowa Kirin initiated Phase 3 trial of tenapanor in Japan. source
$RCKT +3.5% Positive long-term data from RP-L201 trial reported at CIS 2021. source
$GILD +0.6% Granted accelerated approval of Trodelvy for metastatic urothelial cancer. source
$GALT +9% Phase 1 data published in Journal for ImmunoTherapy of Cancer on Belapectin. source
$AZN +1.3% Approves Tagrisso in China in early lung cancer. source
Finance Updates
$PCRX +1.7% Filed lawsuit against ASA over false and misleading info about EXPAREL in medical journal. source
$BCRX +5.2% Approves Japanese NHI price listing of ORLADEYO. source
$RNLX +2.4% Enters into exclusive option agreement with Joslin Diabetes Center for patent filings. source